Phathom Pharmaceuticals Stock Target Price
| PHAT Stock | USD 13.81 0.28 2.07% |
Phathom Pharmaceuticals' fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Phathom Stock price.
Phathom | Target Price | Build AI portfolio with Phathom Stock |
Phathom Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Phathom Pharmaceuticals' direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Phathom Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Phathom Pharmaceuticals by comparing valuation metrics of similar companies.Phathom Pharmaceuticals is currently under evaluation in target price category among its peers.
Phathom Pharmaceuticals Current Valuation Drivers
We derive many important indicators used in calculating different scores of Phathom Pharmaceuticals from analyzing Phathom Pharmaceuticals' financial statements. These drivers represent accounts that assess Phathom Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Phathom Pharmaceuticals' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 1.1B | 727.8M | 438.9M | 468.3M | 513.0M | 665.2M | |
| Enterprise Value | 865.4M | 635.9M | 380.6M | 225.9M | 259.8M | 246.8M |
Phathom Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Phathom Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Phathom Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Phathom Fundamentals
| Return On Equity | -34.89 | ||||
| Return On Asset | -0.59 | ||||
| Profit Margin | (2.90) % | ||||
| Operating Margin | (1.52) % | ||||
| Current Valuation | 894.95 M | ||||
| Shares Outstanding | 70.94 M | ||||
| Shares Owned By Insiders | 4.45 % | ||||
| Shares Owned By Institutions | 82.86 % | ||||
| Number Of Shares Shorted | 14.13 M | ||||
| Price To Book | 25.37 X | ||||
| Price To Sales | 8.42 X | ||||
| Revenue | 55.25 M | ||||
| Gross Profit | 99.11 M | ||||
| EBITDA | (261.52 M) | ||||
| Net Income | (334.33 M) | ||||
| Cash And Equivalents | 207.39 M | ||||
| Cash Per Share | 5.39 X | ||||
| Total Debt | 554.95 M | ||||
| Debt To Equity | 2.43 % | ||||
| Current Ratio | 9.93 X | ||||
| Book Value Per Share | (5.79) X | ||||
| Cash Flow From Operations | (266.77 M) | ||||
| Short Ratio | 10.40 X | ||||
| Earnings Per Share | (4.67) X | ||||
| Target Price | 21.38 | ||||
| Number Of Employees | 427 | ||||
| Beta | 0.44 | ||||
| Market Capitalization | 959.87 M | ||||
| Total Asset | 378.32 M | ||||
| Retained Earnings | (1.26 B) | ||||
| Working Capital | 274.41 M | ||||
| Net Asset | 378.32 M |
About Phathom Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Phathom Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phathom Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phathom Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Phathom Stock Analysis
When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.